Urinary Markers Show Promise in ASD - Scorecard - MDSpire

Urinary Markers Show Promise in ASD

Findings add to growing evidence in favor of microbiome-associated metabolite analysis for ASD screening and stratification

  • June 15, 2026

  • 3 min

Share

Clinical Scorecard: Urinary Markers Show Promise in ASD

At a Glance

CategoryDetail
ConditionAutism Spectrum Disorder (ASD)
Key MechanismsMicrobially derived metabolites in urine
Target PopulationChildren aged 2 to 11 years with ASD
Care SettingLaboratory-based screening

Key Highlights

  • Findings suggest potential for objective biomarkers in neurodevelopmental disorders.

Guideline-Based Recommendations

Diagnosis

  • Use a panel of urinary microbially derived metabolites for identifying ASD subgroups.

Management

  • Further validation of metabolite profiles is needed before clinical application.

Monitoring & Follow-up

  • Monitor metabolite levels to assess potential ASD characteristics.

Risks

  • Study limitations include small sample size and exclusion of children with known genetic causes.

Patient & Prescribing Data

Children with ASD and neurotypical controls aged 2 to 11 years.

Metabolite elevations vary significantly among individuals.

Clinical Best Practices

  • Utilize established LC-MS methods for metabolite analysis.
  • Consider multi-analyte signatures rather than single biomarkers for diagnosis.

Related Resources & Content

Original Source(s)

Urinary Markers Show Promise in ASD

  • June 15, 2026

Related Content

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.

Mesonephric-like adenocarcinoma of the uterine corpus: a case report